FDA Approves Tirzepatide for Obstructive Sleep Apnea in Obesity
Tirzepatide’s approval marks the first and only prescription medicine available for adults with moderate-to-severe obstructive sleep apnea and obesity.
Related Articles
AI is trained to spot warning signs in blood tests
AI can spot patterns in the data from blood tests that can give an early warning of disease.
Hope on the Horizon: 2 Food Allergy Breakthroughs in 2024
Kim, Sindher, Huffaker spoke with HCPLive about some of the year’s most important developments in the food allergy space, namely the approvals of omalizumab and…
Spotify Employees Say It’s Promoting Fake Artists to Reduce Royalty Payments to Real Ones
According to a shocking new book, Spotify has been promoting “ghost artists” so it can avoid paying piddling royalties to real artists.Â
Cate Blanchett worries AI could ‘totally replace anyone’
Cate Blanchett admitted she is “deeply concerned” about the impact of artificial intelligence in Hollywood and beyond as her agency partners with YouTube to police…
Meet the AI boxing official who’ll be ringside for Fury v Usyk this weekend
TYSON FURY’S rematch with Oleksandr Usyk tomorrow night is set to be judged by an AI official. The Gypsy King’s bid to dethrone Usyk and…
Three Specialists Perform Robotic Surgery to Remove Endometrial Nodule
A team of Cleveland Clinic surgical specialists performed a robot-assisted procedure for a patient with a history of cancer and a complex case of endometriosis.
Eli Lilly’s obesity drug Zepbound approved to treat sleep apnea in U.S.
The FDA has cleared Eli Lilly’s obesity drug Zepbound as the first treatment for obstructive sleep apnea in the U.S.
Talking to Kids About Serious Illnesses
There are no absolute right or wrong ways to tell a child about a loved one’s serious health diagnosis. But a child psychologist shares strategies…
Iowa HHS Reports First Human Case of Highly Pathogenic Avian Influenza (HPAI) in Iowa, Risk Remains Very Low to Public
Iowa HHS reports first human case of avian influenza.
FDA Approves First Medication for Obstructive Sleep Apnea
Today, the FDA approved the first medication for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.
